Tuesday, October 18, 2016

Covonia Herbal Mucus Cough Syrup





1. Name Of The Medicinal Product



Allens Pine and Honey Balsam



Covonia Herbal Mucus Cough Syrup


2. Qualitative And Quantitative Composition



Ipecacuanha liquid extract 0.0076ml/5ml



Liquorice liquid extract 0.l25m1/5ml



Squill oxymel 0.78ml/5ml



For full list of excipients, see section 6.1



3. Pharmaceutical Form



Syrup



4. Clinical Particulars



4.1 Therapeutic Indications



A traditional herbal remedy used for relief of the symptoms of coughs, colds and bronchitis.



4.2 Posology And Method Of Administration



Oral



Recommended doses and dosage schedule



Adults and children over 12 years: l0ml



Elderly: dose as for adults, unless otherwise directed.



The dose may be repeated after 4 hours if required.



4.3 Contraindications



Squill should not be administered to patients with impaired renal function, and is inadvisable in patients with cardiac disorders. Sensitivity to colophony containing products e.g. some lipsticks and eyeshadows etc.



Children under 12 years of age



4.4 Special Warnings And Precautions For Use



Shake the bottle.



Keep all medicines away from children.



Do not give to children under 12 years.



4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction



Administration with carbenoxolone or diuretics may cause increased toxicity of squill if hypokalaemia occurs.



4.6 Pregnancy And Lactation



All drugs should be avoided if possible during the first trimester. Insufficient evidence is available to indicate safety of this product during pregnancy or lactation.



4.7 Effects On Ability To Drive And Use Machines



No effects known.



4.8 Undesirable Effects



Adverse effects of squill include nausea and vomiting, which may also be caused by ipecacuanha which has an irritant effect on the gastrointestinal tract. Emetine is known to accumulate in muscle and may interfere with muscle fibre contactility of heart muscle.



Liquorice may cause reversible sodium retention and potassium loss leading to hypertension, water retention and electrolyte imbalance.



4.9 Overdose



The symptoms of overdose of squill and ipecacuanha include nausea and vomiting. Treatment of overdose would depend upon the symptoms, cardiac irregularities, which may be caused by squill, may be treated by emesis or aspiration and lavage. In cases of severe cardiac arrhythmias, potassium and/or anti-arrhythmic agents may be given. Prolonged vomiting may be a symptom of overdose of ipecacuanha alkaloids, which may be controlled by intramuscular injection of 25 -50mg of chlorpromazine or of a comparable dose of a related phenothiazine; fluid and electrolyte imbalance should also be corrected.



5. Pharmacological Properties



5.1 Pharmacodynamic Properties



Squill is used for its reflex expectorant action. Liquorice acts as a demulcent and expectorant. Ipecacuanha, in small doses, has a reflex expectorant action useful for the treatment of the symptoms of acute and chronic bronchitis, and in coughs



5.2 Pharmacokinetic Properties



Several procedures have been reported for the determination of ipecacuanha alkaloids but the classical acid-based titrimetric method would still appear to be the recommended one.



5.3 Preclinical Safety Data



None



6. Pharmaceutical Particulars



6.1 List Of Excipients



Pumilio Pine Oil



Anise oil



Capsicum tincture



Chloroform



Ethanol (96%)



Diethyl ether (peroxide free)



Arrowroot



Menthol



Peppermint oil



Syrup



Treacle black



Purified water



6.2 Incompatibilities



None known



6.3 Shelf Life



150m1: 36 months unopened.



6.4 Special Precautions For Storage



Store below 25°C.



6.5 Nature And Contents Of Container



150ml bottle-amber glass with a child resistant tamper evident 28mm cap with a Melinex/Aluminium/EPE liner.



6.6 Special Precautions For Disposal And Other Handling



None



7. Marketing Authorisation Holder



Thornton & Ross Ltd.,



Linthwaite Laboratories,



Huddersfield,



HD7 5QH



8. Marketing Authorisation Number(S)



PL 00240/5209R



9. Date Of First Authorisation/Renewal Of The Authorisation



02/03/2009



10. Date Of Revision Of The Text



03/02/2011





No comments:

Post a Comment